
Tenpoint Therapeutics is a global, commercial-ready biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye. Its pipeline includes paradigm-shifting therapeutics for ophthalmic indications with significant unmet medical need, including presbyopia, cataracts, and geographic atrophy.
Our lead investigational asset, YUVEZZI™, is designed to be the first and only combination therapy for presbyopia and has received FDA approval on January 28, 2026. We are actively advancing preparations for a commercial launch in the first half of 2026.
This is a launch role. Tenpoint Therapeutics is building a high-performing field team to deliver an exceptional launch for our investigational therapy, Brimochol™ PF, for presbyopia. As a Specialty Sales Manager, you’ll run a startup inside your territory—building relationships with Optometrists and Ophthalmologists, turning clinical value into everyday adoption, and converting first scripts into durable growth. You’ll be the face of the brand and the voice of the field: shaping resources, activating champions, and feeding insights that refine the national playbook. If you thrive on white space, operate with integrity, and love winning with customers, this is your moment to help practices serve more patients—and to put your name on a category-defining launch.
Reports to: Area Sales Director
Key Responsibilities
Qualifications
Mindset & Core Competencies
Compensation
The base salary range for the Specialty Sales Manager is $120,000-160,000 USD annually. Final pay determinations will depend on various factors, including but not limited to experience level, knowledge, skills, and abilities.
Physical Requirements & ADA Statement
This position requires the ability to:
·Travel to client sites, which may involve driving a car or utilizing other forms of transportation like planes, trains, or taxis. Must be able to navigate various environments, including office buildings, parking lots, outdoor settings, and transit centers.
·Operate a computer and communicate effectively in a remote work environment.
·Sit for extended periods, engage in video or phone meetings, and use standard office equipment.
·Lift and transport materials up to 25 pounds occasionally.
Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions of the role.
EEO Statement
We are an Equal Opportunity Employer. Consistent with applicable law, all qualified applicants will receive consideration for employment without regard to race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity, Veteran status, or any other characteristic protected by applicable local laws, regulations and ordinances. If you need assistance and/or a reasonable accommodation due to a disability during the interview process, please place your accommodation request with your recruiting contact.

This page is intended for US audiences only.
Tenpoint Therapeutics Limited is a commercial-ready biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye. Its pipeline includes paradigm-shifting treatments for ophthalmic indications with the greatest need and global market potential, including presbyopia, cataracts, and geographic atrophy.
Its lead asset, BRIMOCHOL PF, is a novel, pupil-modulating investigational therapeutic designed to correct the loss of near vision associated with presbyopia, a condition that impacts nearly 128 million people in the U.S. Tenpoint Therapeutics has completed two large Phase 3 pivotal trials (BRIO-I and BRIO-II) for BRIMOCHOL PF, has filed the NDA and has received a Prescription Drug User Fee Act (PDUFA) date from the US FDA of January 28, 2026. Tenpoint Therapeutics’ leadership team includes ophthalmic industry luminaries with track records of successful approvals and commercialization of blockbuster treatments.